Q1 2022 Holdings
Filed 2022-05-16 | 45 holdings | $72.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $27.7M | 1,345,000 | 38.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $15.2M | 693,000 | 21.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $15.0M | 406,500 | 20.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $7.7M | 175,000 | 10.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $6.7M | 195,500 | 9.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $29.6K | 5,974,800 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $27.0K | 5,903,450 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $22.4K | 3,291,343 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $14.5K | 265,750 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $13.7K | 2,674,031 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CLASS A | 75615P103 | $13.3K | 407,002 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $11.1K | 1,112,500 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $10.4K | 2,379,275 | 0.0% |
| Merus N.V. | COM | N5749R100 | $8.9K | 338,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $8.9K | 2,395,600 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $8.3K | 3,155,098 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $7.6K | 271,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.0K | 251,500 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $5.5K | 477,000 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $5.1K | 3,750,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.1K | 211,000 | 0.0% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $4.9K | 325,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.8K | 943,702 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA4EUR) | CLASS A SHARES | 37611X100 | $3.7K | 929,780 | 0.0% |
| Semler Scientific Inc(SMLR) | COM | 81684M104 | $3.5K | 70,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $3.3K | 376,400 | 0.0% |
| Verastem Inc | COM | 92337C104 | $3.3K | 2,325,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.2K | 136,000 | 0.0% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $3.2K | 166,406 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.9K | 303,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.8K | 710,000 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $2.7K | 763,075 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $2.4K | 984,200 | 0.0% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $2.2K | 2,425,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $1.5K | 790,000 | 0.0% |
| Aveo Pharmaceuticals Inc(0HJQ) | COM NEW | 053588307 | $1.3K | 240,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $1.3K | 255,500 | 0.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $1.3K | 178,800 | 0.0% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $1.2K | 266,100 | 0.0% |
| Avalo Therapeutics Inc | COM | 05338F108 | $1.1K | 1,454,400 | 0.0% |
| Nucana PLC | SPONSORED ADR | 67022C106 | $878 | 878,700 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $793 | 55,678 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $740 | 89,980 | 0.0% |
| Journey Medicine Corp(DERM) | COM | 48115J109 | $324 | 67,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $29 | 16,667 | 0.0% |